187 related articles for article (PubMed ID: 30429029)
1. New risk scoring system for predicting acute exacerbation of interstitial pneumonia after chemotherapy for lung cancer associated with interstitial pneumonia.
Isobe K; Kaburaki K; Kobayashi H; Sano G; Sakamoto S; Takai Y; Makino T; Tochigi N; Iyoda A; Homma S
Lung Cancer; 2018 Nov; 125():253-257. PubMed ID: 30429029
[TBL] [Abstract][Full Text] [Related]
2. A simple risk scoring system for predicting acute exacerbation of interstitial pneumonia after pulmonary resection in lung cancer patients.
Sato T; Kondo H; Watanabe A; Nakajima J; Niwa H; Horio H; Okami J; Okumura N; Sugio K; Teramukai S; Kishi K; Ebina M; Sugiyama Y; Kondo T; Date H
Gen Thorac Cardiovasc Surg; 2015 Mar; 63(3):164-72. PubMed ID: 25352311
[TBL] [Abstract][Full Text] [Related]
3. Preoperative CT Findings for Predicting Acute Exacerbation of Interstitial Pneumonia After Lung Cancer Surgery: A Multicenter Case-Control Study.
Ozawa Y; Shibamoto Y; Hiroshima M; Nakagawa M; Ono A; Hanaoka R; Yamamoto A; Tominaga J; Kawada H; Koyama M; Takumi K; Tsubakimoto M; Egashira R; Tsushima F; Kikuchi Y; Izumi Y; Ushio T; Kimura M; Ichikawa S; Kitamura N; Matsushita S; Okauchi K; O'uchi T; Ishikawa H; Kitase M
AJR Am J Roentgenol; 2021 Oct; 217(4):859-869. PubMed ID: 33852356
[No Abstract] [Full Text] [Related]
4. Autoantibody Positivity Is a Risk Factor for Chemotherapy-induced Exacerbation of Interstitial Pneumonia in Lung Cancer.
Ito N; Masuda T; Nakashima T; Nakao S; Yamaguchi K; Sakamoto S; Horimasu Y; Miyamoto S; Iwamoto H; Fujitaka K; Hamada H; Hattori N
Anticancer Res; 2021 Mar; 41(3):1497-1506. PubMed ID: 33788742
[TBL] [Abstract][Full Text] [Related]
5. The utility of ground-glass attenuation score for anticancer treatment-related acute exacerbation of interstitial lung disease among lung cancer patients with interstitial lung disease.
Nishiyama N; Honda T; Sema M; Kawahara T; Jin Y; Natsume I; Chiaki T; Yamashita T; Tsukada Y; Taki R; Miyashita Y; Saito K; Tateishi T; Sakashita H; Miyazaki Y
Int J Clin Oncol; 2020 Feb; 25(2):282-291. PubMed ID: 31720993
[TBL] [Abstract][Full Text] [Related]
6. Serum S100 calcium-binding protein A4 as a novel predictive marker of acute exacerbation of interstitial pneumonia after surgery for lung cancer.
Kagimoto A; Tsutani Y; Kushitani K; Kambara T; Mimae T; Miyata Y; Takeshima Y; Okada M
BMC Pulm Med; 2021 Jun; 21(1):186. PubMed ID: 34078355
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and risk of cytotoxic chemotherapy in extensive disease-small cell lung cancer patients with interstitial pneumonia.
Shirasawa M; Fukui T; Kusuhara S; Hiyoshi Y; Nakahara Y; Nishinarita N; Igawa S; Naoki K
BMC Cancer; 2019 Feb; 19(1):163. PubMed ID: 30808322
[TBL] [Abstract][Full Text] [Related]
8. Postoperative pyothorax a risk factor for acute exacerbation of idiopathic interstitial pneumonia following lung cancer resection.
Kobayashi S; Karube Y; Nishihira M; Inoue T; Araki O; Maeda S; Sado T; Matsumura Y; Chida M
Gen Thorac Cardiovasc Surg; 2016 Aug; 64(8):476-80. PubMed ID: 27277761
[TBL] [Abstract][Full Text] [Related]
9. The extent of ground-glass attenuation is a risk factor of chemotherapy-related exacerbation of interstitial lung disease in patients with non-small cell lung cancer.
Masuda T; Hirano C; Horimasu Y; Nakashima T; Miyamoto S; Iwamoto H; Ohshimo S; Fujitaka K; Hamada H; Hattori N
Cancer Chemother Pharmacol; 2018 Jan; 81(1):131-139. PubMed ID: 29143072
[TBL] [Abstract][Full Text] [Related]
10. Low forced vital capacity predicts cytotoxic chemotherapy-associated acute exacerbation of interstitial lung disease in patients with lung cancer.
Enomoto Y; Inui N; Kato T; Baba T; Karayama M; Nakamura Y; Ogura T; Suda T
Lung Cancer; 2016 Jun; 96():63-7. PubMed ID: 27133752
[TBL] [Abstract][Full Text] [Related]
11. Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases.
Suda T; Kaida Y; Nakamura Y; Enomoto N; Fujisawa T; Imokawa S; Hashizume H; Naito T; Hashimoto D; Takehara Y; Inui N; Nakamura H; Colby TV; Chida K
Respir Med; 2009 Jun; 103(6):846-53. PubMed ID: 19181509
[TBL] [Abstract][Full Text] [Related]
12. Outcomes in surgically managed non-small-cell lung cancer patients with evidence of interstitial pneumonia identified on preoperative radiology or incidentally on postoperative histology.
Maniwa T; Kondo H; Mori K; Sato T; Teramukai S; Ebina M; Kishi K; Watanabe A; Sugiyama Y; Date H
Interact Cardiovasc Thorac Surg; 2015 May; 20(5):641-6. PubMed ID: 25712985
[TBL] [Abstract][Full Text] [Related]
13. The ATS/ERS/JRS/ALAT statement "IPF by HRCT" could predict acute exacerbation of interstitial lung disease in non-small cell lung cancer.
Asai N; Katsuda E; Hamanaka R; Kosaka K; Matsubara A; Nishimura M; Tanaka H; Yokoe N; Takahashi A; Yamaguchi E; Kubo A
Tumori; 2017 Jan; 103(1):60-65. PubMed ID: 27791236
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of bevacizumab on chemotherapy-related acute exacerbation of interstitial lung disease in patients with advanced non-squamous non-small cell lung cancer.
Hamada S; Ichiyasu H; Ikeda T; Inaba M; Kashiwabara K; Sadamatsu T; Sato N; Akaike K; Okabayashi H; Saruwatari K; Tomita Y; Saeki S; Hirata N; Yoshinaga T; Fujii K
BMC Pulm Med; 2019 Apr; 19(1):72. PubMed ID: 30940113
[TBL] [Abstract][Full Text] [Related]
15. Glasgow prognostic score for prediction of chemotherapy-triggered acute exacerbation interstitial lung disease in patients with small cell lung cancer.
Kikuchi R; Takoi H; Tsuji T; Nagatomo Y; Tanaka A; Kinoshita H; Ono M; Ishiwari M; Toriyama K; Kono Y; Togashi Y; Yamaguchi K; Yoshimura A; Abe S
Thorac Cancer; 2021 Jun; 12(11):1681-1689. PubMed ID: 33939332
[TBL] [Abstract][Full Text] [Related]
16. What factors determine the survival of patients with an acute exacerbation of interstitial lung disease after lung cancer resection?
Miyajima M; Watanabe A; Sato T; Teramukai S; Ebina M; Kishi K; Sugiyama Y; Kondo H; Kobayashi S; Takahashi Y; Ito H; Yamamoto R; Sawada S; Fujimori H; Okabe K; Arikura J; Shintani Y; Nakamura H; Toyooka S; Hasumi T; Watanabe T; Hata Y; Iwata H; Aoki M; Funai K; Inoue S; Kawashima O; Iida T; Date H
Surg Today; 2018 Apr; 48(4):404-415. PubMed ID: 29124429
[TBL] [Abstract][Full Text] [Related]
17. Clinical features and outcome of acute exacerbation of interstitial pneumonia: collagen vascular diseases-related versus idiopathic.
Tachikawa R; Tomii K; Ueda H; Nagata K; Nanjo S; Sakurai A; Otsuka K; Kaji R; Hayashi M; Katakami N; Imai Y
Respiration; 2012; 83(1):20-7. PubMed ID: 21912082
[TBL] [Abstract][Full Text] [Related]
18. Analysis of acute exacerbation of interstitial lung disease associated with chemotherapy in patients with lung cancer: A feasibility of S-1.
Kakiuchi S; Hanibuchi M; Tezuka T; Saijo A; Otsuka K; Sakaguchi S; Toyoda Y; Goto H; Kawano H; Azuma M; Ogushi F; Nishioka Y
Respir Investig; 2017 Mar; 55(2):145-152. PubMed ID: 28274530
[TBL] [Abstract][Full Text] [Related]
19. Postoperative acute exacerbation of interstitial pneumonia in pulmonary and non-pulmonary surgery: a retrospective study.
Miyamura T; Sakamoto N; Kakugawa T; Okuno D; Yura H; Nakashima S; Ishimoto H; Kido T; Taniguchi D; Miyazaki T; Tsuchiya T; Tsutsui S; Yamaguchi H; Obase Y; Ishimatsu Y; Ashizawa K; Nagayasu T; Mukae H
Respir Res; 2019 Jul; 20(1):154. PubMed ID: 31307466
[TBL] [Abstract][Full Text] [Related]
20. Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis.
Park IN; Kim DS; Shim TS; Lim CM; Lee SD; Koh Y; Kim WS; Kim WD; Jang SJ; Colby TV
Chest; 2007 Jul; 132(1):214-20. PubMed ID: 17400667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
